The mechanism of Tylenol toxicity is most likely inducing...

Chris Masterjohn@ChrisMasterjohn
13 views
Sep 23, 2025
~4 min read
Advertisement
1
The mechanism of Tylenol toxicity is most likely inducing mitochondrial function by depleting mitochondrial glutathione and occurs biochemically at any dose.
π§΅π
π§΅π
2
Acetaminophen (paracetamol, N-acetyl-p-aminophenol, APAP) is used by 50 million American adults per week but in high doses contributes to centrilobular necrosis that results in 10,000 hospital visits and 500 deaths per year, accruing direct costs of almost $90 million annually [5, 7].
3
The mechanisms of acetaminophen-induced hepatic necrosis have been reviewed in [7], listed at end.
4
Acetaminophen generates a small but predictable amount of N-acetyl-p-benzoquinoneimine (NAPQI) during its metabolism.
5
Mice and hamsters are sensitive to APAP-induced necrosis, while rats are less sensitive. In mice, most cell death occurs by necrosis and less than one percent occurs by apoptosis.
6
Cytochrome P450 (CYP) enzymes including CYP1A2, CYP3A4, CYP26D, and especially CYP2E1 metabolize APAP to NAPQI by direct, two-electron oxidation.
7
. Glutathione (GSH) non-enzymatically reduces NAPQI back to APAP or conjugates NAPQI to form 3-glutathion-S-yl-APAP via GSH S-transferase pi (GST-Ο).
8
As a result, cellular GSH concentrations decline by over 90 percent during APAP toxicity.
9
Once the GSH concentration declines below a critical level, NAPQI begins covalently binding to at least 22 identified proteins.
10
Knockout of GST-Ο, however, lowers the level of GSH depletion to 70 percent and attenuates hepatotoxicity without affecting covalent protein binding, suggesting that GSH depletion is more critical to hepatotoxicity than covalent binding.
11
This right here implies that it is glutathione depletion and not direct toxicity of NAPQI that mediates toxicity, but wait for the mitochondrial conclusion.
12
At low doses, APAP is effectively processed by glucuronylation and sulfation and excreted in the urine [6].
13
The immediate reaction of the cell that encounters even non-toxic doses of APAP is to upregulate its defenses against toxins and oxidants through the nuclear factor E2-related factor 2 (Nrf2) pathway [6].
14
Thus, GSH depletion and oxidative stress induced by NAPQI initially upregulate a wide battery of cellular defenses, but as the dose becomes more toxic, these defenses are overwhelmed both by the quantitative excess of oxidative stress and by the destruction of the proteins involved in the response.
15
Treatment of patients with N-acetyl-cysteine (NAC), a GSH precursor and potential direct scavenger of NAPQI, mitigates toxicity during this stage, corresponding to the first ten hours after overdose [7].
16
While severe GSH depletion is necessary for APAP toxicity, diethylmaleate causes similar depletions of GSH without causing similar toxicity [7] and N-acetyl-m-aminophenol (AMAP), a regioisomer of APAP, generates a metabolite so reactive that it never diffuses to the mitochondria, and is non-toxic even at high doses [5].
17
This here implies that glutathione depletion itself cannot be the explanation of toxicity and opens the possibility that diffusion to mitochondria of the reactive metabolite may be necessary.
18
Thiol oxidation and GSH depletion within the mitochondria can activate the mitochondrial membrane permeabilization transition (MPT) pore, which depolarizes the inner membrane [5].
19
Inhibition of the MPT pore with cyclosporine A reduces APAP toxicity in mice [7].
20
This directly supports a role of mitochondrial toxicity in the well-established hepatotoxicity of acetaminophen.
21
The iron-chelator desferal prevents APAP-induced increases in cytosolic Fe2+ and mitochondrial membrane depolarization when it is provided to cells free or conjugated to starch [19].
22
Conjugation to starch locks desferal within the lysosomal/endosomal compartments and the efficacy of this form suggests that the release of lysosomal Fe2+ mediates APAP-induced mitochondrial membrane depolarization [19].
23
This Fe2+ would be expected to diffuse to the mitochondria and aggravate oxidative stress by interacting with H2O2 to generate the hydroxyl radical [20].
24
Activation of the MPT pore mediated by oxidative stress and GSH depletion leads to outer membrane rupture, inner membrane and matrix herniation, and release of cytochrome C, which triggers apoptotic signaling [20].
25
[20]. Depolarization of the inner membrane, however, stops ATP synthesis; if a sufficient number of mitochondria in the cell suffer this type of damage before apoptosis can be achieved, ATP deprivation will convert the apoptotic process to necrosis [20].
26
Some authors, however, have warned that we cannot rule out the possibility that Fe2+ is acting as an enzyme cofactor rather than a Fenton catalyst in this model [7].
27
Thus there is lack of clarity on exact mechanisms, but something is depleting mitochondrial glutathione in this model and that appears necessary for its toxicity.
28
As to whether this occurs at normal doses, the biochemical toxicity of NAPQI does indeed, and the depletion of glutathione is itself the primary mechanism of toxicity.
It may be clinically safe from the perspective of hepatotoxicity, but that does not mean nothing bad is happening biochemically.
It may be clinically safe from the perspective of hepatotoxicity, but that does not mean nothing bad is happening biochemically.
29
Thus it is entirely plausible and well worthy of investigation whether taxing the glutathione pool contributes to asthma, autism, or any other such problem.
30
5. Han, D., et al., Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol, 2010(196): p. 267-310.
6.Srivastava, A., et al., Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol, 2010(196): p. 165-94.
7.Hinson, J.A., D.W. Roberts, and L.P. James, Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol, 2010(196): p. 369-405.
19. Jones, D.P., et al., Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv, 2010. 10(2): p. 98-111.
20.Pessayre, D., et al., Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol, 2010(196): p. 311-65.
6.Srivastava, A., et al., Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol, 2010(196): p. 165-94.
7.Hinson, J.A., D.W. Roberts, and L.P. James, Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol, 2010(196): p. 369-405.
19. Jones, D.P., et al., Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv, 2010. 10(2): p. 98-111.
20.Pessayre, D., et al., Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol, 2010(196): p. 311-65.